These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 3664462

  • 1. Flow cytometry analysis of DNA damage and the evaluation of cytotoxicity of alkylating agents.
    Frankfurt OS.
    Cancer Res; 1987 Nov 01; 47(21):5537-41. PubMed ID: 3664462
    [Abstract] [Full Text] [Related]

  • 2. Flow cytometric analysis of DNA damage and repair in the cells resistant to alkylating agents.
    Frankfurt OS, Seckinger D, Sugarbaker EV.
    Cancer Res; 1990 Aug 01; 50(15):4453-7. PubMed ID: 2369722
    [Abstract] [Full Text] [Related]

  • 3. Intercellular transfer of drug resistance.
    Frankfurt OS, Seckinger D, Sugarbaker EV.
    Cancer Res; 1991 Feb 15; 51(4):1190-5. PubMed ID: 1997161
    [Abstract] [Full Text] [Related]

  • 4. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.
    Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B.
    Cancer Res; 1988 Jan 01; 48(1):19-26. PubMed ID: 3334994
    [Abstract] [Full Text] [Related]

  • 5. Detection of DNA damage in individual cells by flow cytometric analysis using anti-DNA monoclonal antibody.
    Frankfurt OS.
    Exp Cell Res; 1987 Jun 01; 170(2):369-80. PubMed ID: 3036552
    [Abstract] [Full Text] [Related]

  • 6. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA, Herman TS, Tanaka J, Eder JP, Holden SA, Bubley G, Coleman CN, Frei E.
    Cancer Res; 1991 Feb 15; 51(4):1086-91. PubMed ID: 1825474
    [Abstract] [Full Text] [Related]

  • 7. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 15; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 8. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K, Shrieve DC.
    J Natl Cancer Inst; 1987 Oct 15; 79(4):811-5. PubMed ID: 3477662
    [Abstract] [Full Text] [Related]

  • 11. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
    Anderson CP, Reynolds CP.
    Bone Marrow Transplant; 2002 Aug 15; 30(3):135-40. PubMed ID: 12189530
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of L-phenylalanine mustard and L-buthionine sulfoximine on murine and human hematopoietic progenitor cells in vitro.
    Du DL, Volpe DA, Grieshaber CK, Murphy MJ.
    Cancer Res; 1990 Jul 01; 50(13):4038-43. PubMed ID: 2354454
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective enhancement of hypoxic cell killing by melphalan via thiol depletion: in vitro studies with hypoxic cell sensitizers and buthionine sulfoximine.
    Roizin-Towle L.
    J Natl Cancer Inst; 1985 Jan 01; 74(1):151-7. PubMed ID: 3155814
    [Abstract] [Full Text] [Related]

  • 17. Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo.
    Teicher BA, Holden SA, Eder JP, Brann TW, Jones SM, Frei E.
    Cancer Res; 1989 Nov 01; 49(21):5994-8. PubMed ID: 2790813
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of DNA repair in cells treated with a combination of alkylating agents.
    Frankfurt OS, Seckinger D, Sugarbaker EV.
    Anticancer Res; 1993 Nov 01; 13(4):947-52. PubMed ID: 8352564
    [Abstract] [Full Text] [Related]

  • 19. Cell cycle-dependent cytotoxicity of alkylating agents: determination of nitrogen mustard-induced DNA cross-links and their repair in Chinese hamster ovary cells synchronized by centrifugal elutriation.
    Murray D, Meyn RE.
    Cancer Res; 1986 May 01; 46(5):2324-9. PubMed ID: 3697977
    [Abstract] [Full Text] [Related]

  • 20. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
    Muldoon LL, Walker-Rosenfeld SL, Hale C, Purcell SE, Bennett LC, Neuwelt EA.
    J Pharmacol Exp Ther; 2001 Mar 01; 296(3):797-805. PubMed ID: 11181909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.